Drug profile · INN
nipocalimab-aahu
IMAAVY
nipocalimab-aahu (IMAAVY) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Drug details — nipocalimab-aahu
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
nipocalimab-aahu (IMAAVY) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Recent coverage
Frequently asked questions
What is nipocalimab-aahu?
nipocalimab-aahu (IMAAVY) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for nipocalimab-aahu?
IMAAVY is a marketed brand name for nipocalimab-aahu. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nipocalimab-aahu?
nipocalimab-aahu has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.